Genetic propensity for higher levels of arachidonic acid is linked to a lower risk of bipolar disorder

Genetic propensity for higher levels of arachidonic acid is linked to a lower risk of bipolar disorder

A genetic propensity for higher circulating levels of lipids containing arachidonic acid, an omega-6 polyunsaturated fatty acid found in eggs, poultry and seafood, has been found to be linked to a lower risk of bipolar disorder , according to a new study a Biological Psychiatry, published by Elsevier. This new evidence paves the way for … Read more

Enhancing neurogenesis for the treatment of Parkinson’s – Neuroscience News

Neuroscience News logo for mobile.

Summary: Researchers have pioneered a method to enhance the generation of dopaminergic neurons, crucial for the treatment of Parkinson’s disease, by targeting specific receptors within the Wnt signaling pathway. Using synthetic antibodies, the team successfully directed stem cell differentiation in the midbrain to produce these key neurons, which are critical to brain health and are … Read more

Researchers develop a genetic test for the early detection of high cardiovascular risk

Researchers develop a genetic test for the early detection of high cardiovascular risk

Credit: Unsplash/CC0 Public Domain Clonal hematopoiesis is a phenomenon caused by mutations in hematopoietic stem cells and can lead to blood cancer. We now know that it also occurs in people with normal blood counts, where it is associated with an increased risk of life-threatening atherosclerotic cardiovascular disease. A research team at the Medical University … Read more

May 1, 2024

May 1, 2024

The MN-GEMS grant management system is up and running MN-GEMS, the University’s new scholarship management tool, is now available. MN-GEMS, which replaces EGMS, a custom platform built 25 years ago, will align the U of M’s proposal submission and award process with 25 other top research universities. The University’s Sponsored Projects Administration, which oversaw the … Read more

Garvan Institute and Illumina collaborate to transform the treatment of complex diseases

Garvan Institute and Illumina collaborate to transform the treatment of complex diseases

Illumina, a global genomics and human health company, has partnered with the Garvan Institute of Medical Research’s TenK10K project to help transform the treatment of complex diseases, starting with autoimmune diseases, with a joint investment of $27 million Australians The Garvan Institute plans to map 50 million human cells from 10,000 people to identify unique … Read more